Odorranain-C1

General Information


DRACP ID  DRACP00178

Peptide Name   Odorranain-C1

Sequence  GVLGAVKDLLIGAGKSAAQSVLKTLSCKLSNDC

Sequence Length  33

UniProt ID  Not available

PubChem CID  Not available

Origin  Odorrana grahami

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A549 Lung adenocarcinoma Carcinoma IC50=27.31 µM MTT assay 24h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=41.21 µM MTT assay 24h 1
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50=52.83 µM MTT assay 24h 1
LoVo Colon adenocarcinoma Carcinoma IC50=55.22 µM MTT assay 24h 1

Hemolytic Activity  Human erythrocytes: 0% Hemolysis=50 µg/ml; Sheep erythrocytes: <10% Hemolysis=256 µM

Normal (non-cancerous) Cytotoxicity  Human mast cells: 2.9±1.5% degranulation=50 µg/ml; HEK293T: IC50=48.7 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00178

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys27<--->Cys33

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C140H247N39O45S2

Absent amino acids  EFHMPRWY

Common amino acids  L

Mass  383186

Pl  8.81

Basic residues  4

Acidic residues  2

Hydrophobic residues  14

Net charge  2

Boman Index  -787

Hydrophobicity  51.52

Aliphatic Index  121.21

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  125

Absorbance 280nm  3.91

Polar residues  12

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34073203

Title  Prediction of Anticancer Peptides with High Efficacy and Low Toxicity by Hybrid Model Based on 3D Structure of Peptides

Doi 10.3390/ijms22115630

Year  2021

Literature 2

Pubmed ID 17272268

Title  Anti-infection peptidomics of amphibian skin

Doi 10.1074/mcp.M600334-MCP200

Year  2007

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.